GELESIS HOLDINGS, INC.

Gelesis Holdings, Inc., trading under ticker CPSR, was formed through the business combination of Capstar Special Purpose Acquisition Corp — sponsored by Capstar Sponsor LLC — and Gelesis, a healthcare company focused on weight-management therapeutics. The SPAC completed its IPO in 2021 and closed its merger with Gelesis in January 2022, bringing the biotech into the public markets under the healthcare sector. By the time this 8-K was filed on June 13, 2023, Gelesis was navigating significant financial and operational challenges following a Chapter 11 bankruptcy filing earlier that year. Visit SpacDesk and sign up for full filing history, event timelines, and deal analytics on CPSR and hundreds of other SPAC transactions.